Gastro-oesophageal reflux is listed as a common side effect (up to 1 in 10 people) with some GLP-1 medications, particularly during initial dose titration
8 Similarly, Gotera et al
Learning Objectives Upon completion of the Advanced Weight Management Certification program, the physician should be able to: Learn about the latest weight loss programs and protocols available including: GLP-1 Agonist Training: Receive in-depth instruction on the use of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy), in weight loss treatments
puede aclarar sus dudas sobre cmo se hereda la deficiencia de CAT, qu opciones tiene en futuros embarazos y qu pruebas estn disponibles para el resto de la familia
Actually, I was involved with one of them, Rimonabant and did the large trial, which as you know, led to having to stop the drug, discontinue it because it was associated with suicidal ideation and actual some suicide